Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP288417.RAQCIdY4F0rIhqqPMMFgELpC6CqR2JCbT0nTg69K9bQgk130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP288417.RAQCIdY4F0rIhqqPMMFgELpC6CqR2JCbT0nTg69K9bQgk130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP288417.RAQCIdY4F0rIhqqPMMFgELpC6CqR2JCbT0nTg69K9bQgk130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP288417.RAQCIdY4F0rIhqqPMMFgELpC6CqR2JCbT0nTg69K9bQgk130_provenance.
- NP288417.RAQCIdY4F0rIhqqPMMFgELpC6CqR2JCbT0nTg69K9bQgk130_assertion description "[Generalized alterations in beta-adrenergic signalling, including betaARK1, could be a major contributory factor in the development of LVH in hypertension, and the concentration of betaARK1 in lymphocytes can reflect the development of LVH in a patient with hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP288417.RAQCIdY4F0rIhqqPMMFgELpC6CqR2JCbT0nTg69K9bQgk130_provenance.
- NP288417.RAQCIdY4F0rIhqqPMMFgELpC6CqR2JCbT0nTg69K9bQgk130_assertion evidence source_evidence_literature NP288417.RAQCIdY4F0rIhqqPMMFgELpC6CqR2JCbT0nTg69K9bQgk130_provenance.
- NP288417.RAQCIdY4F0rIhqqPMMFgELpC6CqR2JCbT0nTg69K9bQgk130_assertion SIO_000772 15097244 NP288417.RAQCIdY4F0rIhqqPMMFgELpC6CqR2JCbT0nTg69K9bQgk130_provenance.
- NP288417.RAQCIdY4F0rIhqqPMMFgELpC6CqR2JCbT0nTg69K9bQgk130_assertion wasDerivedFrom befree-20140225 NP288417.RAQCIdY4F0rIhqqPMMFgELpC6CqR2JCbT0nTg69K9bQgk130_provenance.
- NP288417.RAQCIdY4F0rIhqqPMMFgELpC6CqR2JCbT0nTg69K9bQgk130_assertion wasGeneratedBy ECO_0000203 NP288417.RAQCIdY4F0rIhqqPMMFgELpC6CqR2JCbT0nTg69K9bQgk130_provenance.
- befree-20140225 importedOn "2014-02-25" NP288417.RAQCIdY4F0rIhqqPMMFgELpC6CqR2JCbT0nTg69K9bQgk130_provenance.